DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TEBANICLINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TEBANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9KX8NKV538
Molecule Type:
Small molecule
Molecular Formula:
C9H11ClN2O
Molecular Weight:
198.65
AlogP:
1.48
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SGS-742
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
GABA-B receptor antagonist
SGS-742
×
Maximum Phase:
2
First Approval:
None
UNII:
GBZ5UC0RME
Molecule Type:
Small molecule
Molecular Formula:
C7H18NO2P
Molecular Weight:
179.2
AlogP:
1.41
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
6.0
Source:
EPETRABOROLE
2
Small molecule
Investigational
Unknown
Unknown
Infections
Leucine--tRNA ligase inhibitor
EPETRABOROLE
×
Maximum Phase:
2
First Approval:
None
UNII:
6MC93Z2DF9
Molecule Type:
Small molecule
Molecular Formula:
C11H16BNO4
Molecular Weight:
237.06
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
SEPANTRONIUM BROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Prostatic Neoplasms
Unknown
SEPANTRONIUM BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
7H5Q4J1CM5
Molecule Type:
Small molecule
Molecular Formula:
C20H19BrN4O3
Molecular Weight:
443.3
AlogP:
1.34
PSA:
77.96
HBD:
0.0
HBA:
#RotB:
5.0
Source:
VIDUPIPRANT
2
Small molecule
Investigational
Unknown
Unknown
Asthma
G protein-coupled receptor 44 antagonist
VIDUPIPRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
61OTZ32XNC
Molecule Type:
Small molecule
Molecular Formula:
C28H27Cl2FN2O6S
Molecular Weight:
609.5
AlogP:
6.76
PSA:
121.8
HBD:
3.0
HBA:
#RotB:
9.0
Source:
JNJ-49095397
2
Small molecule
Investigational
Unknown
Unknown
Respiratory Syncytial Virus Infections; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal
Unknown
JNJ-49095397
×
Maximum Phase:
2
First Approval:
None
UNII:
I92MU0V408
Molecule Type:
Small molecule
Molecular Formula:
C34H36N6O4
Molecular Weight:
592.7
AlogP:
6.83
PSA:
119.4
HBD:
3.0
HBA:
#RotB:
9.0
Source:
ADELMIDROL
2
Small molecule
Investigational
Unknown
Unknown
Vaginitis
Unknown
ADELMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
1BUC3685QU
Molecule Type:
Small molecule
Molecular Formula:
C13H26N2O4
Molecular Weight:
274.36
AlogP:
-0.07
PSA:
98.66
HBD:
4.0
HBA:
#RotB:
12.0
Source:
INCYCLINIDE
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Neoplasms
Unknown
INCYCLINIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
21G64WZQ4I
Molecule Type:
Small molecule
Molecular Formula:
C19H17NO7
Molecular Weight:
371.35
AlogP:
0.58
PSA:
158.15
HBD:
5.0
HBA:
#RotB:
1.0
Source:
SITAFLOXACIN
2
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Bacterial DNA gyrase inhibitor
SITAFLOXACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
45IP57B62B
Molecule Type:
Small molecule
Molecular Formula:
C19H18ClF2N3O3
Molecular Weight:
409.82
AlogP:
2.7
PSA:
88.56
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FOSMANOGEPIX
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Candidemia; Mycoses
GPI-anchored wall transfer protein 1 inhibitor
FOSMANOGEPIX
×
Maximum Phase:
2
First Approval:
None
UNII:
1XQ871489P
Molecule Type:
Small molecule
Molecular Formula:
C22H21N4O6P
Molecular Weight:
468.41
AlogP:
2.21
PSA:
147.64
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AMCASERTIB
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Cholangiocarcinoma; Gastrointestinal Stromal Tumors; Ovarian Neoplasms; Urinary Bladder Neoplasms
Unknown
AMCASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
GLY8ABW25V
Molecule Type:
Small molecule
Molecular Formula:
C31H33N5O2S
Molecular Weight:
539.71
AlogP:
5.99
PSA:
90.12
HBD:
3.0
HBA:
#RotB:
9.0
Source:
LY-2606368
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Ovarian Neoplasms
Serine/threonine-protein kinase Chk1 inhibitor
LY-2606368
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FALLYPRIDE
2
Small molecule
Investigational
Unknown
Unknown
Obesity, Morbid; Obesity
Unknown
FALLYPRIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
G9FWZ369GX
Molecule Type:
Small molecule
Molecular Formula:
C20H29FN2O3
Molecular Weight:
364.46
AlogP:
2.99
PSA:
50.8
HBD:
1.0
HBA:
#RotB:
10.0
Source:
E-7016
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Melanoma
Unknown
E-7016
×
Maximum Phase:
2
First Approval:
None
UNII:
M8926C7ILX
Molecule Type:
Small molecule
Molecular Formula:
C20H19N3O3
Molecular Weight:
349.39
AlogP:
2.65
PSA:
78.45
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ATOPAXAR
2
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome; Coronary Disease
Proteinase-activated receptor 1 antagonist
ATOPAXAR
×
Maximum Phase:
2
First Approval:
None
UNII:
HTI275SD2D
Molecule Type:
Small molecule
Molecular Formula:
C29H38FN3O5
Molecular Weight:
527.64
AlogP:
4.79
PSA:
84.32
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PERPHENAZINE 4-AMINOBUTYRATE
2
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
PERPHENAZINE 4-AMINOBUTYRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
K1WO7H97QZ
Molecule Type:
Small molecule
Molecular Formula:
C25H33ClN4O2S
Molecular Weight:
489.09
AlogP:
4.23
PSA:
62.04
HBD:
1.0
HBA:
#RotB:
10.0
Source:
TETRADECYLTHIOACETIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TETRADECYLTHIOACETIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
7ZU5I25S2O
Molecule Type:
Small molecule
Molecular Formula:
C16H32O2S
Molecular Weight:
288.5
AlogP:
5.51
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
15.0
Source:
ABX-464
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Colitis, Ulcerative; Crohn Disease; HIV Infections; Severe Acute Respiratory Syndrome
Cap binding complex modulator
ABX-464
×
Maximum Phase:
2
First Approval:
None
UNII:
26RU378B9V
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClF3N2O
Molecular Weight:
338.72
AlogP:
5.53
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PUERARIN
2
Small molecule
Investigational
Unknown
Unknown
Alcoholism; Arthritis, Rheumatoid; Cardiovascular Diseases
Unknown
PUERARIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Z9W8997416
Molecule Type:
Small molecule
Molecular Formula:
C21H20O9
Molecular Weight:
416.38
AlogP:
0.39
PSA:
160.82
HBD:
6.0
HBA:
#RotB:
3.0
Source:
MK-0893
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Glucagon receptor antagonist
MK-0893
×
Maximum Phase:
2
First Approval:
None
UNII:
CCP2U6LWTP
Molecule Type:
Small molecule
Molecular Formula:
C32H27Cl2N3O4
Molecular Weight:
588.49
AlogP:
7.5
PSA:
93.45
HBD:
2.0
HBA:
#RotB:
9.0
Source:
SF-1126
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Neoplasms; Neuroblastoma; Carcinoma, Squamous Cell
PI3-kinase class I inhibitor
SF-1126
×
Maximum Phase:
2
First Approval:
None
UNII:
DL0Q912033
Molecule Type:
Small molecule
Molecular Formula:
C39H48N8O14
Molecular Weight:
852.86
AlogP:
-2.87
PSA:
341.7
HBD:
9.0
HBA:
#RotB:
22.0
Source:
ABT-072
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
ABT-072
×
Maximum Phase:
2
First Approval:
None
UNII:
PSQ4R5K1QI
Molecule Type:
Small molecule
Molecular Formula:
C24H27N3O5S
Molecular Weight:
469.56
AlogP:
3.37
PSA:
110.26
HBD:
2.0
HBA:
#RotB:
6.0
Source:
RAF-265
2
Small molecule
Investigational
Unknown
Unknown
Melanoma; Neoplasms
Serine/threonine-protein kinase B-raf inhibitor
RAF-265
×
Maximum Phase:
2
First Approval:
None
UNII:
8O434L3768
Molecule Type:
Small molecule
Molecular Formula:
C24H16F6N6O
Molecular Weight:
518.42
AlogP:
6.93
PSA:
80.65
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ARQ 087
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ARQ 087
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06459988
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
PF-06459988
×
Maximum Phase:
2
First Approval:
None
UNII:
5IE92SK9EB
Molecule Type:
Small molecule
Molecular Formula:
C19H22ClN7O3
Molecular Weight:
431.88
AlogP:
2.13
PSA:
110.19
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SAGOPILONE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Glioblastoma; Melanoma; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma
Tubulin stabiliser
SAGOPILONE
×
Maximum Phase:
2
First Approval:
None
UNII:
KY72JU32FO
Molecule Type:
Small molecule
Molecular Formula:
C30H41NO6S
Molecular Weight:
543.73
AlogP:
5.46
PSA:
109.25
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AZM-475271
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase ABL inhibitor
AZM-475271
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GTS-21
2
Small molecule
Investigational
Unknown
Unknown
Autistic Disorder; Obesity; Alzheimer Disease; Psychotic Disorders; Schizophrenia; Tobacco Use Disorder
Unknown
GTS-21
×
Maximum Phase:
2
First Approval:
None
UNII:
8S399XDN2K
Molecule Type:
Small molecule
Molecular Formula:
C19H20N2O2
Molecular Weight:
308.38
AlogP:
3.77
PSA:
43.71
HBD:
0.0
HBA:
#RotB:
4.0
Source:
RISLENEMDAZ
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major
Glutamate NMDA receptor; GRIN1/GRIN2B antagonist
RISLENEMDAZ
×
Maximum Phase:
2
First Approval:
None
UNII:
5HAM167S5T
Molecule Type:
Small molecule
Molecular Formula:
C19H23FN4O2
Molecular Weight:
358.42
AlogP:
3.19
PSA:
67.35
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TEZAMPANEL
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Glutamate receptor ionotropic AMPA antagonist
TEZAMPANEL
×
Maximum Phase:
2
First Approval:
None
UNII:
GA36S2O9C2
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O2
Molecular Weight:
279.34
AlogP:
0.61
PSA:
103.79
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DM-CHOC-PEN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DM-CHOC-PEN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CGC-11047
2
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CGC-11047
×
Maximum Phase:
2
First Approval:
None
UNII:
2C4Y86R2AX
Molecule Type:
Small molecule
Molecular Formula:
C14H32N4
Molecular Weight:
256.44
AlogP:
0.72
PSA:
48.12
HBD:
4.0
HBA:
#RotB:
14.0
Source:
REZATOMIDINE
2
Small molecule
Investigational
Unknown
Unknown
Cystitis, Interstitial; Diabetic Neuropathies; Fibromyalgia; Irritable Bowel Syndrome
Unknown
REZATOMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
W5LMZ0RC8I
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2S
Molecular Weight:
232.35
AlogP:
3.84
PSA:
31.58
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PYRIDOXAMINE
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Nephropathies; Kidney Calculi
Unknown
PYRIDOXAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
6466NM3W93
Molecule Type:
Small molecule
Molecular Formula:
C8H12N2O2
Molecular Weight:
168.2
AlogP:
0.05
PSA:
79.37
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GISADENAFIL
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Erectile Dysfunction; Prostatic Hyperplasia; Urinary Bladder, Overactive
Phosphodiesterase 5A inhibitor
GISADENAFIL
×
Maximum Phase:
2
First Approval:
None
UNII:
S6G4R7DI1C
Molecule Type:
Small molecule
Molecular Formula:
C23H33N7O5S
Molecular Weight:
519.63
AlogP:
1.12
PSA:
135.54
HBD:
1.0
HBA:
#RotB:
10.0
Source:
1
2
…
132
133
134
135
136
137
138
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA